Adastra Receives Controlled Substances Dealer’s License

CANADA: Adastra Holdings Ltd., a leading cannabis company focused on processing, adult-use and medical sales, organoleptic testing and analytical testing, is pleased to announce that the Company has received its Controlled Drug and Substances Dealer’s License on August 24, 2022. This license allows Adastra to process psilocybin and psilocin, the active compounds derived from psychedelic Read the full article...
http://dlvr.it/SXYQMd

Comments

Popular posts from this blog

Ohio Board of Pharmacy Publishes Updated Patient & Caregiver Numbers for October 2021

KBS Sells TOBY Award-Winning 675,945 Square-Foot Class A Mixed-Use Property in Downtown Los Angeles, California for $104 Million